Help Pass the CREATES Act | Association for Accessible Medicines
AAM Statement - President Trump’s Blueprint to Lower Drug Prices
CBS News February 2, 2018

Help Pass the CREATES Act

Anticompetitive practices prevent patients from accessing the generic and biosimilar medicines they need.

Congress is currently considering a fix, the Creating and Restoring Equal Access to Equivalent Samples (“CREATES”) Act. Encourage your members of Congress to pass this important bill that will bring down costs and increase patient access to life-saving medicines. 

Watch this CBS News story that explains the challenge facing so many Americans, like cancer patient, Pam Holt. You, like Pam, can make a difference. 

How critics say drug companies play "games" to stave off generic competitors (Video)

(Play Video) How critics say drug companies play "games" to stave off generic competitors

Read Article
 

Contact your lawmaker today and ask them to support the CREATES Act:

Take Action

 

Kristin Murphy


By Kristin Murphy, AAM Director, Federal Affairs

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.